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DISCUSSION
Dr William Jordan (Birmingham, Ala). Thank you, Dr Hu-
ber, Dr Hansen. First I want to congratulate Dr Lee on his
eloquent presentation of the continued scholarly pursuits at the
University of Florida. In this series he and his colleagues presented
a 5-year experience with endovascular repair of 171 aneurysms.
Most of the experience is in the last 22 years, which reflects a wave
of endo-enthusiasm that has swept across our southern region and
our country. The authors identified the ability to expand this
minimally invasive approach to an additional 14% of their patients.
Specifically, this is most often related to the difficulty with the
access through the iliofemoral segment to place these large-diam-
eter endografts into the aneurysm proper. Dr Lee has demon-
strated to us that the retroperitoneal approach can offer an ap-
proach for iliac conduit or for iliofemoral bypass or for direct
hypogastric revascularization. While their operative time, blood
loss, and total complication rate were increased, the overall mor-
tality was similar. Anthony, your determination should be ap-
plauded, as you have expanded the application of this technique to
more patients, yet you still remain under Dr Sternbergh’s endo-
enthusiasm limit of 60%.
Now, to address the concept of iliac access, I would like to
borrow from the motif of the recent film of Tolkein’s Lord of the
Rings. You remind me of Balrog, who stood before Gandalf on the
bridge of Kaza-dum in the Mines of Moria. The wizard exclaimed
to the demon that “Thou shalt not pass,” yet you found a way to
get around these small iliac arteries or to address large common
iliacs. I want to direct three questions to you, please.
First, you used 8 mm as a minimum diameter to avoid femoral
access. Were all the patients that were imaged who had an iliac
artery less than 8 mm then committed to a retroperitoneal ap-
proach? In our experience at UAB we found that many smaller
iliacs could be gently dilated with dilators or with balloon angio-
plasty. Furthermore, how many of the 40% of patients with open
repairs were denied endovascular repair because of iliac access
problems? It seems that the AneuRx device could be passed
through 7 mm vessels, and even smaller vessels, if calcification is
limited. How much did calcification play a role in your decision to
go directly to the retroperitoneal access versus an attempt at
transfemoral approach?
Second, some have suggested the procedure is simple and not
much more involved than the femoral approach. However, these
operations required more time and had more blood loss than the
standard femoral approach, as you have shown us here. Addition-
ally, there were more patients who suffered an ileus after this
retroperitoneal approach, suggesting that there may still be some
intraperitoneal insult to this maximally exposed, minimally invasive
operation. Your increased complication rates approach some re-
ports of open repair. Some then may advocate the more durable
open reconstruction rather than this approach outlined here. Why
not just open the patient up? You used a retroperitoneal incision
for internal iliac revascularization in 16 or 17 cases, which repre-
sents almost 10% of your total endovascular experience. In the
manuscript you also noted a 15% claudication rate in this group. In
our experience in Birmingham, we have often used hypogastric
embolization, and rarely use revascularization, but seem to have a
similar claudication rate after the procedure. Are you convinced
that adding this bypass is necessary for patients, also realizing that
many are in such ill health that they do not undertake such
vigorous activity to even have hip claudication?
Finally, I have some issue about your high-risk classification.
You use the anesthesiologist classification system, which too often
may seem subjective and motivated differently from factors that the
surgeon traditionally uses to assess a patient. Have you categorized
other risk factors, such as degree of coronary artery disease or
ventricular function, and their effect on perioperative morbidity
and mortality?
Again, Anthony, I enjoyed the paper. I am thankful that you
were able to forward it to me well in advance of the meeting, and
I also ask that all in the audience realize that this is an aggressive
approach toward challenging iliac anatomy that we all face, and
that you also have been able to overcome those prohibitions of the
gray-haired Gandalf, who suggested that you shall not pass. So,
Anthony, Sir Balrog, how do you respond? Thank you.
Dr W. Anthony Lee. Will, thank you for that discussion. I
think the current situation is that we have the skills to overcome
some of these unfavorable iliac anatomies and that they, in and of
themselves, should not deny somebody who may strongly wish
an endovascular treatment of their aneurysms, and certainly if
their comorbid status would make endovascular repair a more
attractive option. Specifically, external iliac arteries that are
less than 8 mm are a significant risk factor for intraoperative
complications. Indeed, two patients had inadvertent retroperito-
neal exposures after external iliac artery ruptures. We have tried
all sorts of adjunctive maneuvers, including serial, hydrophilic
dilators and balloon angioplasties, and in a couple of cases we have
actually put in a covered stent preoperatively to superdilate these
arteries. None of these methods were successful in our hands. That
is the main reason for going directly to these retroperitoneal
conduits.
In regard to your question about the remaining 40% who were
not eligible for endovascular repair, the 40% was due to proximal
neck issues that could not be overcome.
Did calcification play a role? Yes, certainly it did. Even in
marginally sized arteries, if they are relatively free of calcifications,
it is possible to pass 22F sheaths.
I would not term these retroperitoneal procedures, whether
they are iliac conduits or hypogastric bypasses, as simple. I think
they are fairly involved, and our data regarding their procedure
time and postoperative morbidity also supports that. Why not,
then, convert these or offer them an open aneurysm repair from the
start? Well, the answers to that reflect what I said earlier about
some people who strongly desire endovascular repair, or their
comorbid status may sometimes sway one toward that route.
Although the data are not presented in this paper, it is our
retroperitoneal experience that, despite the incremental surgical
stress of these procedures, when you see them back in clinic they
are functionally better than people who have undergone open
aneurysm repair.
With regard to the indications for hypogastric artery bypass,
about 3 years ago three papers were published in two separate
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journals by the Stanford, MGH, and Montefiore groups that
addressed the morbidity of hypogastric artery occlusion. These
three groups independently reported a 35% to 40% risk of postop-
erative buttock claudication and some form of pelvic ischemia. It
has been our position that whenever you can save the hypogastric
artery it should be preserved. Having said that, for people who are
not that ambulatory and who do have significant comorbid disease,
we have offered hypogastric embolization, provided the contralat-
eral hypogastric artery is patent.
Last, our definition of so-called high risk. I knew that would
stir up some controversy. We chose the ASA classification simply
because that is the best we had. We have over 10 different classifi-
cations of comorbid disease, and none of them really played out to
be significant except the presence of peripheral occlusive disease.
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